Search

everythinglearnresearchcommunity

for

Search:↓

Robotic-assisted hair transplant is effective and less painful, but needs more evaluation for long-term results.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Some medications can help increase sexual desire and function in women.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Skin reactions from cancer treatments might predict how well the treatments work.

Microneedling radiofrequency significantly improves hair growth with minimal side effects.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Combining microneedling with 2% minoxidil is more effective and safe for treating female pattern hair loss than using minoxidil alone.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Baricitinib effectively regrows hair in severe alopecia areata cases.

The weight loss drug Orlistat can cause liver damage and should be used with caution, especially in those with liver or kidney issues.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.